MedPath

Mechanisms of transcranial alternating current stimulation modulating frontoparietal network to enhance working memory in patients with mild cognitive impairment

Phase 1
Recruiting
Conditions
Mild Cognitive Impairment
Registration Number
ChiCTR2400089078
Lead Sponsor
Shanghai Mental Health Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Aged 65 years or older;<br>(2) Cognitive concern reflecting a change in cognition reported by patient self or informant or clinician, scores on cognitive tests for individuals with MCI are 1.5 standard deviations below the mean for their age and education-matched peers on culturally appropriate normative data;<br>(3) Preservation of independence in functional abilities.<br>(4) Except for other conditions that can cause cognitive impairment, not demented with a CDR score of 0.5;<br>(5) Right handness.<br><br>

Exclusion Criteria

(1) Physical disability;<br>(2) Significant communication and mobility difficulties;<br>(3) Severe vision loss;<br>(4) History of otitis media, Meniere's disease, episodes of vertigo, ototoxic drug use, and family history of deafness;<br>(5) Severe physical illness (e.g., chronic illnesses such as hypertension, heart disease, severe liver disease, etc., except when the illness is stable under medication control);<br>(6) Central nervous system disorders such as epilepsy, cerebrovascular disease, traumatic brain injury, infectious encephalopathy, brain tumors, dementia, etc;<br>(7) Patients with major depression, schizophrenia, presence of psychotic symptoms, depressive episodes, suicidal ideation or behavior, and other psychiatric symptoms that may interfere with the implementation of the research protocol, and long-term psychotropic medication; <br>(8) Any previous active immunotherapy 6 months prior to screening;<br>(9) Alcohol use within 30 days, history of alcohol dependence, and other psychoactive substance abuse<br>(10) Patients with contraindications (e.g. presence of pacemaker and metal implant) to MRI scanning; <br>(11) Those who are unable to complete cognitive function tests due to various conditions;<br>(12) Those attending other clinical trials 30 days prior to screening.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
repeatable battery for the assessment of neuropsychological status;auditory verbal learning test;
Secondary Outcome Measures
NameTimeMethod
working memory task;executive functions;changes in Neuroimage changes in Magnetic Resonance Imaging;changes in electroencephalogram;
© Copyright 2025. All Rights Reserved by MedPath